[Therapy of primary open-angle glaucoma by oftan-dipivefrin].

Choice of optimal hypotensive therapy with the minimal side effects remains a serious problem in therapy of glaucoma. The efficacy and safety of oftan-dipivefrin (Sante, Finland) and glaucon (Alcon, USA) are compared in a controlled balanced randomized open parallel study preceded by a period for discharge of the previous drugs. The period of discharge was 7 days, active treatment was administered for 8 weeks.

[Xalathane: comparative assessment of efficacy and safety in hypotensive therapy of glaucoma].

Hypotensive efficacy and safety of local monotherapy with 0.005% xalathane (once a day) and combined therapy with 0.5% timolol (twice a day) and 2% pilocarpine (3 times a day) are compared in 24 patients with primary open-angle glaucoma.

[Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma].

The efficacy of timoptic depot is assessed in 20 patients with open-angle glaucoma, previously treated with 0.25 and 0.5% timolol.